EFFECTS OF Cl2MDP-ENCAPSULATING LIPOSOMES IN A MURINE MODEL OFPSEUDOMONAS AERUGINOSA-INDUCED SEPSIS
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 12 (3) , 239-257
- https://doi.org/10.1081/lpr-120014760
Abstract
Pseudomonas aeruginosa is a pathogen that frequently causes acute lung injury, bacteremia and sepsis in critically ill patients. As tissue macrophages are a major producer of inflammatory mediators that contribute to septic physiology, and are essential for eliminating bacteria from the circulation, we investigated the role of tissue macrophages in the generation of both inflammatory and anti-inflammatory cytokines in septic shock by using our mouse model of P. aeruginosa pneumonia. To see the effects of tissue macrophage depletion, we intravenously injected dichloromethylene-diphosphonate (Cl2MDP)-encapsulating liposomes in mice. Two days after the liposome injection, we instilled cytotoxic P. aeruginosa (PA103) into the lung that disseminates and causes septic shock. After the infection, we collected blood and bronchoalveolar lavage fluids. The samples were then analyzed for TNF-α, MIP-2, and IL-10 concentration. We compared these results to control mice that received either liposomes without Cl2MDP or phosphate buffered saline alone. Plasma TNF-α, MIP-2, and IL-10 levels were significantly decreased in the tissue macrophage-depleted mice compared to the control groups of mice. Although depletion of tissue macrophages by Cl2MDP-liposome administration did not affect the severity of bacteremia or the survival of infected mice, these results imply that tissue macrophages have a major role in the production of both proinflammatory and anti-inflammatory cytokines in the circulation and in the causing septic physiology associated with P. aeruginosa pneumonia.Keywords
This publication has 19 references indexed in Scilit:
- Therapeutic Administration of Anti-PcrV F(ab′)2 in Sepsis Associated with Pseudomonas aeruginosaThe Journal of Immunology, 2001
- Pathogenesis of septic shock in Pseudomonas aeruginosa pneumoniaJournal of Clinical Investigation, 1999
- Type III Secretion Machines: Bacterial Devices for Protein Delivery into Host CellsScience, 1999
- Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injuryNature Medicine, 1999
- ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injuryMolecular Microbiology, 1997
- Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathwayMolecular Microbiology, 1996
- THE PATHOGENESIS OF SEPSIS: Factors That Modulate the Response to Gram-Negative Bacterial InfectionClinics in Chest Medicine, 1996
- Ventilator-Associated Pneumonia Due to Pseudomonas AeruginosaChest, 1996
- Bacteremic Nosocomial PneumoniaChest, 1995
- Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stayThe American Journal of Medicine, 1993